| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |